SCHEMBL4308965

SCHEMBL4308965

COCCCN1CCN(Cc2ccc(C=Cc3n[nH]c4ccccc34)c(N)c2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.44
FLT1 P17948 2/20 0.44
AURKA O14965 5/20 0.41
AURKB Q96GD4 5/20 0.41
PARP1 P09874 1/20 0.39
PDGFRB P09619 1/20 0.39
KDR P35968 1/20 0.39
HTR1D P28221 1/20 0.37
HTR1B P28222 1/20 0.37
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
CHEK1 O14757 1/20 0.36
DRD2 P14416 2/20 0.35
HTR1A P08908 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HRH1 P35367 1/20 0.35
ACHE P22303 2/20 0.35
BCHE P06276 1/20 0.35
CHRNB2 P17787 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4308960 1.00 FGFR1 (0.44) FGFR1FLT1AURKAAURKBPARP1
SCHEMBL4322802 0.88 FGFR1 (0.43) FGFR1FLT1AURKAAURKBPDGFRB
SCHEMBL4322813 0.88 FGFR1 (0.43) FGFR1FLT1AURKAAURKBPDGFRB
SCHEMBL4314498 0.86 FGFR1 (0.45) FGFR1FLT1AURKAAURKBPDGFRB
SCHEMBL4314489 0.86 FGFR1 (0.45) FGFR1FLT1AURKAAURKBPDGFRB
SCHEMBL4308105 0.83 PARP1 (0.39) FGFR1FLT1AURKAAURKBPARP1
SCHEMBL4308112 0.83 PARP1 (0.39) FGFR1FLT1AURKAAURKBPARP1
SCHEMBL4317933 0.81 FGFR1 (0.42) FGFR1FLT1AURKAAURKBDRD2
SCHEMBL27711632 0.81 FGFR1 (0.43) FGFR1FLT1AURKAAURKBPARP1
SCHEMBL4317941 0.81 FGFR1 (0.42) FGFR1FLT1AURKAAURKBDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 FGFR1 18/4885FLT1 81/4885AURKA 3687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.